Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion type Assertion NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_head.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion description "[Glioblastomas frequently carry genetic alterations resulting in an aberrant activation of the phosphoinositol-3-kinase (Pi3k)/protein kinase B (Akt) signalling pathway, including most notably phosphatase and tensin homolog (PTEN) mutation, epidermal growth factor receptor (EGFR) amplification and rearrangement, as well as carboxyl-terminal modulator protein (CTMP) hypermethylation [Knobbe et al., (2004) Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_provenance.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion evidence source_evidence_literature NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_provenance.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion SIO_000772 16150119 NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_provenance.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion wasDerivedFrom befree-2016 NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_provenance.
- NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_assertion wasGeneratedBy ECO_0000203 NP512538.RAU1rqnO2R2ZJ2-UZjoosvK474GblbQt5I0ROypQuDz_M130_provenance.